Glenmark Pharma gains on getting US FDA’s nod for Norethindrone Acetate, Ethinyl Estradiol Tablets

07 Apr 2015 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 849.00, up by 1.05 points or 0.12% from its previous closing of Rs. 847.95 on the BSE.

The scrip opened at Rs. 854.00 and has touched a high and low of Rs. 857.65 and Rs. 836.05 respectively. So far 45729 shares were traded on the counter.

The BSE group 'A' stock of face value Re. 1 has touched a 52 week high of Rs. 879.05 on 20-Mar-2015 and a 52 week low of Rs. 510.00 on 19-May-2014.

Last one week high and low of the scrip stood at Rs. 862.20 and Rs. 780.80 respectively. The current market cap of the company is Rs. 23032.91 crore.

The promoters holding in the company stood at 48.31 % while Institutions and Non-Institutions held 41.03 % and 10.66 % respectively.

Glenmark Generics Inc (GGI), a step down subsidiary of Glenmark Pharmaceuticals, has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5 mcg and 1 mg/5 mcg. Glenmark will commence distribution of the product immediately.

Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5 mcg and 1 mg/5 mcg are Glenmark's generic version of Warner Chilcott's FemHRT. Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5 mcg and 1 mg/5 mcg are indicated for the treatment of moderate to severe vasomotor symptoms due to menopause and for the prevention of postmenopausal osteoporosis in women at significant risk of osteoporosis. For the 12 month period ending February 2015, the FemHRT market garnered annual sales of $38.6 Million according to IMS Health.

Glenmark’s current portfolio consists of 96 products authorized for distribution in the U.S. marketplace and 69 ANDA's pending approval with the US FDA. In addition to these internal filings, GGI continues to identify and explore external development partnerships to supplement and accelerate the growth of the existing pipeline and portfolio.

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×